Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma

Otília Menyhárt, Ádám Nagy, B. Györffy

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Potential prognostic biomarker candidates for hepatocellular carcinoma (HCC) are abundant, but their generalizability is unexplored. We cross-validated markers of overall survival (OS) and vascular invasion in independent datasets. Methods: The literature search yielded 318 genes related to survival and 52 related to vascular invasion. Validation was performed in three datasets (RNA-seq, n = 371; Affymetrix arrays, n = 91; Illumina gene chips, n = 135) by uni- A nd multivariate Cox regression and Mann-Whitney U-test, separately for Asian and Caucasian patients. Results: One hundred and eighty biomarkers remained significant in Asian and 128 in Caucasian subjects at p < 0.05. After multiple testing correction BIRC5 (p = 1.9 × 10-10), CDC20 (p = 2.5 × 10-9) and PLK1 (p = 3 × 10-9) endured as best performing genes in Asian patients; however, none remained significant in the Caucasian cohort. In a multivariate analysis, significance was reached by stage (p = 0.0018) and expression of CENPH (p = 0.0038) and CDK4 (p = 0.038). KIF18A was the only gene predicting vascular invasion in the Affymetrix and Illumina cohorts (p = 0.003 and p = 0.025, respectively). Conclusion: Overall, about half of biomarker candidates failed to retain prognostic value and none were better than stage predicting OS. Impact: Our results help to eliminate biomarkers with limited capability to predict OS and/or vascular invasion.

Original languageEnglish
Article number181006
JournalRoyal Society Open Science
Volume5
Issue number12
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Blood Vessels
Hepatocellular Carcinoma
Biomarkers
Survival
Genes
Nonparametric Statistics
Oligonucleotide Array Sequence Analysis
Multivariate Analysis
RNA
Datasets

Keywords

  • Biomarker
  • Hepatocellular carcinoma
  • Liver cancer
  • Survival
  • Vascular invasion

ASJC Scopus subject areas

  • General

Cite this

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. / Menyhárt, Otília; Nagy, Ádám; Györffy, B.

In: Royal Society Open Science, Vol. 5, No. 12, 181006, 01.12.2018.

Research output: Contribution to journalArticle

@article{e6271e10fbe24a38bf1111d487dba371,
title = "Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma",
abstract = "Background: Potential prognostic biomarker candidates for hepatocellular carcinoma (HCC) are abundant, but their generalizability is unexplored. We cross-validated markers of overall survival (OS) and vascular invasion in independent datasets. Methods: The literature search yielded 318 genes related to survival and 52 related to vascular invasion. Validation was performed in three datasets (RNA-seq, n = 371; Affymetrix arrays, n = 91; Illumina gene chips, n = 135) by uni- A nd multivariate Cox regression and Mann-Whitney U-test, separately for Asian and Caucasian patients. Results: One hundred and eighty biomarkers remained significant in Asian and 128 in Caucasian subjects at p < 0.05. After multiple testing correction BIRC5 (p = 1.9 × 10-10), CDC20 (p = 2.5 × 10-9) and PLK1 (p = 3 × 10-9) endured as best performing genes in Asian patients; however, none remained significant in the Caucasian cohort. In a multivariate analysis, significance was reached by stage (p = 0.0018) and expression of CENPH (p = 0.0038) and CDK4 (p = 0.038). KIF18A was the only gene predicting vascular invasion in the Affymetrix and Illumina cohorts (p = 0.003 and p = 0.025, respectively). Conclusion: Overall, about half of biomarker candidates failed to retain prognostic value and none were better than stage predicting OS. Impact: Our results help to eliminate biomarkers with limited capability to predict OS and/or vascular invasion.",
keywords = "Biomarker, Hepatocellular carcinoma, Liver cancer, Survival, Vascular invasion",
author = "Ot{\'i}lia Menyh{\'a}rt and {\'A}d{\'a}m Nagy and B. Gy{\"o}rffy",
year = "2018",
month = "12",
day = "1",
doi = "10.1098/rsos.181006",
language = "English",
volume = "5",
journal = "Royal Society Open Science",
issn = "2054-5703",
publisher = "The Royal Society",
number = "12",

}

TY - JOUR

T1 - Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma

AU - Menyhárt, Otília

AU - Nagy, Ádám

AU - Györffy, B.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Background: Potential prognostic biomarker candidates for hepatocellular carcinoma (HCC) are abundant, but their generalizability is unexplored. We cross-validated markers of overall survival (OS) and vascular invasion in independent datasets. Methods: The literature search yielded 318 genes related to survival and 52 related to vascular invasion. Validation was performed in three datasets (RNA-seq, n = 371; Affymetrix arrays, n = 91; Illumina gene chips, n = 135) by uni- A nd multivariate Cox regression and Mann-Whitney U-test, separately for Asian and Caucasian patients. Results: One hundred and eighty biomarkers remained significant in Asian and 128 in Caucasian subjects at p < 0.05. After multiple testing correction BIRC5 (p = 1.9 × 10-10), CDC20 (p = 2.5 × 10-9) and PLK1 (p = 3 × 10-9) endured as best performing genes in Asian patients; however, none remained significant in the Caucasian cohort. In a multivariate analysis, significance was reached by stage (p = 0.0018) and expression of CENPH (p = 0.0038) and CDK4 (p = 0.038). KIF18A was the only gene predicting vascular invasion in the Affymetrix and Illumina cohorts (p = 0.003 and p = 0.025, respectively). Conclusion: Overall, about half of biomarker candidates failed to retain prognostic value and none were better than stage predicting OS. Impact: Our results help to eliminate biomarkers with limited capability to predict OS and/or vascular invasion.

AB - Background: Potential prognostic biomarker candidates for hepatocellular carcinoma (HCC) are abundant, but their generalizability is unexplored. We cross-validated markers of overall survival (OS) and vascular invasion in independent datasets. Methods: The literature search yielded 318 genes related to survival and 52 related to vascular invasion. Validation was performed in three datasets (RNA-seq, n = 371; Affymetrix arrays, n = 91; Illumina gene chips, n = 135) by uni- A nd multivariate Cox regression and Mann-Whitney U-test, separately for Asian and Caucasian patients. Results: One hundred and eighty biomarkers remained significant in Asian and 128 in Caucasian subjects at p < 0.05. After multiple testing correction BIRC5 (p = 1.9 × 10-10), CDC20 (p = 2.5 × 10-9) and PLK1 (p = 3 × 10-9) endured as best performing genes in Asian patients; however, none remained significant in the Caucasian cohort. In a multivariate analysis, significance was reached by stage (p = 0.0018) and expression of CENPH (p = 0.0038) and CDK4 (p = 0.038). KIF18A was the only gene predicting vascular invasion in the Affymetrix and Illumina cohorts (p = 0.003 and p = 0.025, respectively). Conclusion: Overall, about half of biomarker candidates failed to retain prognostic value and none were better than stage predicting OS. Impact: Our results help to eliminate biomarkers with limited capability to predict OS and/or vascular invasion.

KW - Biomarker

KW - Hepatocellular carcinoma

KW - Liver cancer

KW - Survival

KW - Vascular invasion

UR - http://www.scopus.com/inward/record.url?scp=85059692725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059692725&partnerID=8YFLogxK

U2 - 10.1098/rsos.181006

DO - 10.1098/rsos.181006

M3 - Article

AN - SCOPUS:85059692725

VL - 5

JO - Royal Society Open Science

JF - Royal Society Open Science

SN - 2054-5703

IS - 12

M1 - 181006

ER -